ANI Pharmaceuticals, Inc. (ANIP) financial statements (2020 and earlier)

Company profile

Business Address 210 MAIN STREET WEST
BAUDETTE, MN 56623
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6043312715516911
Cash and cash equivalents6043312715516911
Receivables71655946221713
Inventory, net of allowances, customer advances and progress billings464138261384
Inventory464138261384
Prepaid expense5534121
Other undisclosed current assets1 1 18 
Total current assets:18215313210319320328
Noncurrent Assets
Property, plant and equipment40382011755
Intangible assets, net (including goodwill)192205232178684412
Goodwill4422222
Intangible assets, net (excluding goodwill)188202230176664210
Regulated entity, other noncurrent assets  0    
Restricted cash and investments5555   
Other noncurrent assets211    
Other undisclosed noncurrent assets362822261711 
Total noncurrent assets:274278281220936017
TOTAL ASSETS:45743141232328526445
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1819884103
Accounts payable11943231
Accrued liabilities3221111
Employee-related liabilities342211 
Taxes payable 5 2 4 
Deferred revenue0
Debt433    
Other undisclosed current liabilities1481432824841
Total current liabilities:171166393212134
Noncurrent Liabilities
Long-term debt and lease obligation656770121113111 
Long-term debt, excluding current maturities656770121113111 
Liabilities, other than long-term debt80 1   
Accounts payable and accrued liabilities   1   
Other liabilities80     
Other undisclosed noncurrent liabilities  128    
Total noncurrent liabilities:7368198121113111 
Total liabilities:2442332371531251244
Stockholders' equity
Stockholders' equity attributable to parent, including:21319717517016014041
Common stock000000 
Treasury stock, value(1)(1)(0)   (0)
Additional paid in capital19718717917316416090
Accumulated other comprehensive loss(6)(0)     
Retained earnings (accumulated deficit)2211(4)(3)(4)(20)(48)
Other undisclosed stockholders' equity attributable to parent      0
Total stockholders' equity:21319717517016014041
TOTAL LIABILITIES AND EQUITY:45743141232328526445

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues216202177129765630
Cost of revenue(65)(73)(79)(49)(13)(11)(10)
Gross profit:1501299880644420
Operating expenses(74)(59)(42)(37)(24)(24)(25)
Other undisclosed operating income (loss)(44)(34)(28)(22)(7)(1)6
Operating income:3235282033201
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(1)(1)0(0)00(0)
Interest and debt expense0(0)(11)(11)(11)(1)(0)
Income from continuing operations before equity method investments, income taxes:323417922190
Other undisclosed income (loss) from continuing operations before income taxes(14)(14)(1)(0)00 
Income from continuing operations before income taxes:182016922190
Income tax expense (benefit)(2)(5)(17)(5)(6)9(0)
Income (loss) from continuing operations:1615(1)415290
Loss from discontinued operations      (0)
Net income (loss):1615(1)415290
Other undisclosed net income attributable to parent      0
Net income (loss) attributable to parent:1615(1)415290
Preferred stock dividends and other adjustments      (5)
Other undisclosed net loss available to common stockholders, basic(0)(0) (0)(0)(0)(0)
Net income (loss) available to common stockholders, basic:1615(1)41529(5)
Other undisclosed net income available to common stockholders, diluted0   00 
Net income (loss) available to common stockholders, diluted:1615(1)41529(5)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):1615(1)415290
Other comprehensive loss(7)(0)     
Comprehensive income (loss), net of tax, attributable to parent:1015(1)415290

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: